313994-32-0 Usage
Uses
Used in Pharmaceutical Research:
H-D-ABU-OTBU HCL is used as a research tool for investigating the nociceptin receptor's role in pain management and addiction treatment. Its high affinity and selectivity make it a valuable compound for studying the receptor's function and potential therapeutic applications.
Used in Pain Management:
H-D-ABU-OTBU HCL is used as a potential therapeutic agent for pain management. Preclinical studies have shown promising results in modulating the nociceptin system, which plays a crucial role in the perception of pain and could offer new avenues for treating chronic and acute pain conditions.
Used in Addiction Treatment:
H-D-ABU-OTBU HCL is used as a potential treatment for addiction. Its interaction with the nociceptin receptor suggests that it may have the ability to modulate the rewarding and reinforcing effects of addictive substances, offering a novel approach to addiction therapy.
Used in Neurobiological Research:
H-D-ABU-OTBU HCL is used as a research compound to explore the neurobiological mechanisms underlying the actions of the nociceptin receptor. This includes studying its effects on mood, anxiety, and stress responses, as well as its potential role in neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 313994-32-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,9,9 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 313994-32:
(8*3)+(7*1)+(6*3)+(5*9)+(4*9)+(3*4)+(2*3)+(1*2)=150
150 % 10 = 0
So 313994-32-0 is a valid CAS Registry Number.
313994-32-0Relevant academic research and scientific papers
New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids
Behrends, Malte,Wagner, Stefan,Kopka, Klaus,Schober, Otmar,Sch?fers, Michael,Kumbhar, Sadhana,Waller, Mark,Haufe, Günter
supporting information, p. 3809 - 3818 (2015/08/03)
Abstract Matrix metalloproteinases (MMPs) are involved in a number of physiological as well as pathological processes such as atherosclerosis and tumorigenesis, where an up-regulation of MMPs is predominant. Fluorinated analogues of the hydroxamate-based
